Boston Trust Walden trims MSCI stake by 12.7%
Alpha Vantage · MarketBeat · · AI-summarised by FinFlash
Boston Trust Walden Corp cut its MSCI Inc. stake by 12.7% in the third quarter, selling 2,116 shares and holding 14,540 shares worth about $7.83 million. Analyst consensus remains a Moderate Buy with an average price target of $683.69. MSCI beat earnings estimates on 12.4% revenue growth and declared a $2.05 quarterly dividend.
Understand the context
Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.